Contact us   |  

Patient stratification in Myelodysplastic Syndromes (Treatment of anemia of low risk MDS)

Patient stratification in Myelodysplastic Syndromes (Treatment of anemia of low risk MDS)

09/07/2020 17:00

Speakers: Uwe Platzbecker

Target: Health professionals
Subnetworks: Myeloid malignancies
Disease Groups: Myelodysplastic syndrome

Prof. Uwe Platzbecker is the Director of the Medical Clinic I, Hematology and Cell Therapy at the University Hospital in Leipzig. He is Member of the International MDS Foundation's Medical & Scientific Advisory Board, Chairman of the European Myelodysplastic Syndromes Cooperative Group (EMSCO) by the ELN and chairman EHA MDS working party (SWG). He is also Board Member of the SAL and the German MDS Study Group (D-MDS) and transcampus Professor of Hematology at the Faculty of Life Science and Medicine at King's College London (UK). Section Editor Leukemia and Editorial Board Journal of Clinical Oncology.